×
For best experience we recommend to activate Javascript in your browser.
GSTK1 antibody (AA 19-222)
The Rabbit Polyclonal anti-GSTK1 antibody has been validated for FACS. It is suitable to detect GSTK1 in samples from Mouse.
Quick Overview for GSTK1 antibody (AA 19-222) (ABIN6992502)
Target
See all GSTK1 Antibodies
GSTK1
(Glutathione S-Transferase kappa 1 (GSTK1))
Reactivity
All reactivities for GSTK1 antibodies
Mouse
Host
All hosts for GSTK1 antibodies
Rabbit
Clonality
All clonalities for GSTK1 antibodies
Polyclonal
Conjugate
All conjugates for GSTK1 antibodies
This GSTK1 antibody is un-conjugated
Application
All applications for GSTK1 antibodies
Flow Cytometry (FACS)
Product Details anti-GSTK1 Antibody
(hide)
Binding Specificity
All epitopes for GSTK1 antibodies
AA 19-222
Purpose
Anti-Glutathione S Transferase Kappa 1 (GSTk1) Polyclonal Antibody
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant Glutathione S Transferase Kappa 1 (GSTk1) corresdonding to Ser19~Ala222 (Accession # Q9DCM2)
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
For flow cytometry, the suggested use of this reagent is 1-5 μL per 10^6 cells in 100 μL volume. Optimal working dilutions could be determined by end user.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
Expiry Date
12 months
Target Details for GSTK1
(hide)
Target
GSTK1
(Glutathione S-Transferase kappa 1 (GSTK1))
Alternative Name
Glutathione S Transferase Kappa 1
Background
GST-K1, GST13, HDCMD47P, Glutathione S-transferase subunit 13
UniProt
Q9DCM2
Recently viewed
(hide)
Chat with us , powered by LiveChat